DIN 02282097 — ORENCIA 250 MG
ORENCIA is a powder for solution of Abatacept marketed by BRISTOL-MYERS SQUIBB CANADA. The full Abatacept monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02282097
- Brand name
- ORENCIA
- Active ingredient
- Abatacept
- Strength
- 250 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Selective T-cell costimulation modulator (biologic DMARD)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Abatacept products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02402475 | ORENCIA | 125 MG | SOLUTION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |